Analysis and Distribution of Esculetin in Plasma and Tissues of Rats after Oral Administration

  • Kim, Ji-Sun (Department of Home Economics, College of Natural Sciences, Korea National Open University) ;
  • Ha, Tae-Youl (Division of Creative Food Science for Health, Korea Food Research Institute) ;
  • Ahn, Jiyun (Division of Creative Food Science for Health, Korea Food Research Institute) ;
  • Kim, Suna (Department of Home Economics, College of Natural Sciences, Korea National Open University)
  • Received : 2014.08.28
  • Accepted : 2014.10.24
  • Published : 2014.12.31


In this study, we developed a method to quantify esculetin (6,7-dihydroxycoumarin) in plasma and tissues using HPLC coupled with ultraviolet detection and measured the level of esculetin in rat plasma after oral administration. The calibration curve for esculetin was linear in the range of 4.8 ng/mL to 476.2 ng/mL, with a correlation coefficient ($r^2$) of 0.996, a limit of detection value of 33.2 ng/mL, and a limit of quantification value of 100.6 ng/mL. Recovery rates for the 95.2 ng/mL and 190.5 ng/mL samples were 95.2% and 100.3%, within-runs and 104.8% and 101.0% between-runs, respectively. The relative standard deviation was less than 7% for both runs. In the pharmacokinetic analysis, the peak plasma esculetin level was reached 5 min after administration ($C_{max}=173.3ng/mL$; $T_{1/2}=45min$; $AUC_{0{\sim}180min}=5,167.5ng{\cdot}min/mL$). At 180 min post-administration (i.e., after euthanasia), esculetin was only detectable in the liver ($30.87{\pm}11.33ng/g$) and the kidney ($20.29{\pm}7.02ng/g$).


  1. Zhou L, Kang J, Fan L, Ma XC, Zhao HY, Han J, Wang BR, Guo DA. 2008. Simultaneous analysis of coumarins and secoiridoids in Cortex Fraxini by high-performance liquid chromatography-diode array detection-electrospray ionization tandem mass spectrometry. J Pharm Biomed Anal 47: 39-46.
  2. Kemal C, Louis-Flamberg P, Krupinski-Olsen R, Shorter AL. 1987. Reductive inactivation of soybean lipoxygenase 1 by catechols: a possible mechanism for regulation of lipoxygenase activity. Biochemistry 26: 7064-7072.
  3. Okada Y, Miyauchi N, Suzuki K, Kobayashi T, Tsutsui C, Mayuzumi K, Nishibe S, Okuyama T. 1995. Search for naturally occurring substances to prevent the complications of diabetes. II. Inhibitory effect of coumarin and flavonoid derivatives on bovine lens aldose reductase and rabbit platelet aggregation. Chem Pharm Bull (Tokyo) 43: 1385-1387.
  4. Wang SY, Lin HS. 2000. Antioxidant activity in fruits and leaves of blackberry, raspberry, and strawberry varies with cultivar and developmental stage. J Agric Food Chem 48: 140-146.
  5. Wang F, Herzmark P, Weiner OD, Srinivasan S, Servant G, Bourne HR. 2002. Lipid products of PI(3)Ks maintain persistent cell polarity and directed motility in neutrophils. Nat Cell Biol 4: 513-518.
  6. Park C, Jin CY, Kim GY, Choi IW, Kwon TK, Choi BT, Lee SJ, Lee WH, Choi YH. 2008. Induction of apoptosis by esculetin in human leukemia U937 cells through activation of JNK and ERK. Toxicol Appl Pharmacol 227: 219-228.
  7. Witaicenis A, Seito LN, Di Stasi LC. 2010. Intestinal anti-inflammatory activity of esculetin and 4-methylesculetin in the trinitrobenzenesulphonic acid model of rat colitis. Chem Biol Interact 186: 211-218.
  8. Lee SY, Lim TG, Chen H, Jung SK, Lee HJ, Lee MH, Kim DJ, Shin A, Lee KW, Bode AM, Surh YJ, Dong Z. 2013. Esculetin suppresses proliferation of human colon cancer cells by directly targeting ${\beta}$-catenin. Cancer Prev Res (Phila) 6: 1356-1364.
  9. Schimmer O, Eschelbach H. 1997. Esculetin in Alchemilla speciosa: identification and antimutagenic properties. Pharmazie 52: 476-478.
  10. Tsai TH, Huang CT, Shum AY, Chen CF. 1999. Simultaneous blood and biliary sampling of esculetin by microdialysis in the rat. Life Sci 65: 1647-1655.
  11. Sales NMR, Pelegrini PB, Goersch MC. 2014. Nutrigenomics: definitions and advances of this new science. J Nutr Metab 2014: 202759.
  12. Issaq HJ, Van QN, Waybright TJ, Muschik GM, Veenstra TD. 2010. Analytical and statistical approaches to metabolomics research. J Sep Sci 32: 2183-2199.
  13. Pereira H, Martin JF, Joly C, Sebedio JL, Pujos-Guillot E. 2010. Development and validation of a UPLC/MS method for a nutritional metabolomic study of human plasma. Metabolomics 6: 207-218.
  14. Li ZL, Zhang L, Tian JK, Zhou WM. 2008. Studies on chemical constituents from leaves of Vaccinium bracteatum. Zhongguo Zhong Yao Za Zhi 33: 2087-2089.
  15. Yang W, Ye M, Liu M, Kong D, Shi R, Shi X, Zhang K, Wang Q, Lantong Z. 2010. A practical strategy for the characterization of coumarins in Radix Glehniae by liquid chromatography coupled with triple quadrupole-linear ion trap mass spectrometry. J Chromatogr A 1217: 4587-4600.
  16. Lake BG. 1999. Coumarin metabolism, toxicity and carcinogenicity: relevance for human risk assessment. Food Chem Toxicol 37: 423-453.
  17. Ritschel WA, Brady ME, Tan HSI. 1979. First-pass effect of coumarin in man. Int J Clin Pharmacol Biopharm 17: 99-103.
  18. Ritschel WA, Brady ME, Tan HS, Hoffmann KA, Yiu IM, Grummich KW. 1977. Pharmacokinetics of coumarin and its 7-hydroxy-metabolites upon intravenous and peroral administration of coumarin in man. Eur J Clin Pharmacol 12: 457-461.

Cited by

  1. Esculetin, a natural coumarin compound, evokes Ca2+ movement and activation of Ca2+-associated mitochondrial apoptotic pathways that involved cell cycle arrest in ZR-75-1 human breast cancer cells vol.37, pp.4, 2016,
  2. Esculetin induces death of human colon cancer cells via the reactive oxygen species-mediated mitochondrial apoptosis pathway vol.39, pp.2, 2015,
  3. Esculetin: A phytochemical endeavor fortifying effect against non-communicable diseases vol.84, 2016,
  4. Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action 2017,
  5. Esculetin Inhibits the Survival of Human Prostate Cancer Cells by Inducing Apoptosis and Arresting the Cell Cycle vol.23, pp.1, 2018,